跳到正文
原文
Endpoints News 生物医药· Max Gelman·· 29 天前AI 评分10

大型临床试验探索 GLP-1 药物用于酒精、药物渴求的治疗

Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings

AI 导读

GLP-1 药物正通过大型临床试验拓展其适应症范围,研究重点为评估其是否能缓解酒精及药物渴求。该探索旨在验证此类在糖尿病和减重领域获批的药物在其他成瘾行为治疗中的潜在价值。

正文

For near­ly as long as they’ve been ap­proved for di­a­betes and weight loss, GLP-1 drugs have cap­tured the pub­lic imag­i­na­tion as a pos­si­ble so­lu­tion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news